Private Wealth Management Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.8K | Buy |
86
+58
| +207% | +$7.29K | ﹤0.01% | 463 |
|
|
2025
Q1 | $3.1K | Sell |
28
-58
| -67% | -$6.42K | ﹤0.01% | 905 |
|
|
2024
Q4 | $11.7K | Buy |
86
+59
| +219% | +$8.05K | ﹤0.01% | 425 |
|
|
2024
Q3 | $3.11K | Sell |
27
-44
| -62% | -$5.07K | ﹤0.01% | 906 |
|
|
2024
Q2 | $9.78K | Buy |
71
+44
| +163% | +$6.06K | ﹤0.01% | 446 |
|
|
2024
Q1 | $3.72K | Hold |
27
| – | – | ﹤0.01% | 727 |
|
|
2023
Q4 | $3.56K | Buy |
+27
| New | +$3.56K | ﹤0.01% | 745 |
|